Jorey Chernett - 13 Aug 2026 Form 4 Insider Report for Starling Oncology, Inc. (TOI)

Reporting relationship: 10%+ Owner
Issuer ticker: TOI
Reported as of: 13 Aug 2026
Net transaction value: +$77,856
SEC form: 4
Accepted by SEC: 17 Aug 2026, 10:13:13 UTC
Prior SEC filing: 22 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Jorey Chernett

Key filing fact

Jorey Chernett filed Form 4 for Starling Oncology, Inc. (TOI) on 17 Aug 2026.

Key facts

This page summarizes Jorey Chernett's Form 4 filing for Starling Oncology, Inc. (TOI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 17 Aug 2026, 10:13.

Change

Previous filing in this sequence was filed on 22 Jul 2026.
Current net transaction value: +$77,856.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002042077 Primary reporting owner

Chernett Jorey

Relationship: 10%+ Owner
Address: 6222 INDIANWOOD TR., BLOOMFIELD HILLS
Signature: /s/ Jorey Chernett
Signature date: 17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TOI transaction

Common Stock

Purchase

Transaction value: $78,480
Shares: +12,000
Change %: +0.11%
Price: $6.54
Shares after: 10,660,858
Date: 14 Aug 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TOI transaction Derivative

Call Option (STLN 19FEB27 $9C)

Sale

Transaction value: $624
Shares: -100
Change %: -100%
Price: $6.24
Shares after: 0
Date: 13 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $9.00
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sale of these call options is a matchable transaction subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.